Cypress Bioscience, Royalty Pharma, Ramius LLC deal

Ramius and Royalty completed their previously announced tender offer for Cypress, acquiring 28.7 million shares (73.6%) at $6.50 per share in cash, or about $186.6 million, to raise the companies' hol...